Testing rimegepant for vestibular migraine
Treatments studied
Part of Brain & nervous system clinical trials.
This trial tests if rimegepant can help reduce dizziness from vestibular migraine. It is for people who have tried at least one other preventive treatment without success and have frequent dizzy days.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be 18 to 75 years old
- Have a diagnosis of vestibular migraine
- Have had more than 4 dizzy days each month for the last 3 months
- Have tried and failed at least one preventive treatment before
- Be willing to fill out an electronic diary at least 80% of the time during a run-in phase
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new medication called rimegepant (a CGRP inhibitor, which targets a protein involved in migraine) against flunarizine (a commonly used preventive) for vestibular migraine. It aims to see if rimegepant works as well as flunarizine in reducing vertigo and dizziness episodes. If you qualify, you may receive one of these medications for several months.
This study observes how vestibular migraine is treated in real-life Chinese clinical practice. It may help researchers understand which treatments work best for people with this condition.
This study tests whether migraine prevention medications, including newer anti-CGRP drugs, can reduce ringing in the ears (tinnitus) in people who have migraine or related headache disorders. If you have had tinnitus for at least 6 months and have a history of migraine, you may be able to join.
This study tests whether a medicine called rimegepant can quickly stop dizziness attacks that are related to migraine. It is for people who have had repeated, moderate-to-severe dizziness spells with migraine-like symptoms.
This study tests whether the medication rimegepant can help prevent chronic migraine in adults. It may be an option if you have frequent migraines and have not tried certain other preventive treatments.
This trial tests whether a medication called rimegepant can prevent migraines when you take it before a known trigger (like exercise or stress). It is for people who get migraines often and can predict when one might happen.
Hear when a new Vestibular Migraine trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.